|Articles|November 15, 2002
- BioPharm International-11-01-2002
- Volume 15
- Issue 11
European Editor's Report ? An Industry Comes of Age
Author(s)Kevin Robinson
by Kevin Robinson, BioPharm International As we approach the end of 2002, biotechnology companies continue to be the standard bearers for innovation in the pharmaceutical industry.
Advertisement
Articles in this issue
almost 23 years ago
Inside Washington: Major Changes Ahead for FDAalmost 23 years ago
Bioinformatics Databases ? Questions of Copyrightalmost 23 years ago
Guest Editorial: Back to the Beginningalmost 23 years ago
You Have Failed . . . A Case Study in Warning Letter Remediationalmost 23 years ago
Survival Guide to FDA Inspections: Part 3, Responding to ObservationsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
In-Vivo Cell Therapy Model Aims to Reduce Manufacturing Challenges
2
2025 PharmSci 360 to Showcase Essential AI Integration and Emerging Technologies
3
Top 10 Questions from CPHI Frankfurt: Building Pharma Resilience a Common Theme
4
Streamlining Procurement and Inventory Management Leads to Increased Productivity
5
